BIOMAT Database Logo BIOMAT Database Logo

[Antiaggregants in the treatment of patients with ischemic heart disease]. 1993

B A Sidorenko, and E N Botolova, and A A Golikova

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D004502 Education, Medical, Continuing Educational programs designed to inform physicians of recent advances in their field. Medical Education, Continuing,Continuing Medical Education,Education, Continuing Medical
D006487 Hemostasis The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION. Hemostases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075202 Contraindications A condition or factor associated with a recipient that makes the use of a drug, procedure, or physical agent improper or inadvisable. Contraindications may be absolute (life threatening) or relative (higher risk of complications in which benefits may outweigh risks). Contraindications, Physical Agent,Medical Contraindications,Agent Contraindication, Physical,Agent Contraindications, Physical,Contraindication,Contraindication, Medical,Contraindication, Physical Agent,Contraindications, Medical,Medical Contraindication,Physical Agent Contraindication,Physical Agent Contraindications
D012426 Russia A country located in north Asia bordering the Arctic Ocean, extending from Europe (the portion west of the Urals) to the North Pacific Ocean. The capital is Moscow. Russian S.F.S.R.,Russian Federation (Europe),Russian SFSR
D017202 Myocardial Ischemia A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION). Heart Disease, Ischemic,Ischemia, Myocardial,Ischemic Heart Disease,Disease, Ischemic Heart,Diseases, Ischemic Heart,Heart Diseases, Ischemic,Ischemias, Myocardial,Ischemic Heart Diseases,Myocardial Ischemias

Related Publications

B A Sidorenko, and E N Botolova, and A A Golikova
[Antiaggregants of thrombocytes in ischemic heart disease].
January 1985, Vutreshni bolesti,
B A Sidorenko, and E N Botolova, and A A Golikova
[Anticoagulants and antiaggregants in ischemic heart disease].
August 1990, Giornale italiano di cardiologia,
B A Sidorenko, and E N Botolova, and A A Golikova
[Hyperbaric oxygenation and antiaggregants: effects on platelet function in patients with ischemic heart disease].
January 1997, Anesteziologiia i reanimatologiia,
B A Sidorenko, and E N Botolova, and A A Golikova
[Prescription of platelet antiaggregants in secondary prevention of ischemic heart disease].
March 1996, Atencion primaria,
B A Sidorenko, and E N Botolova, and A A Golikova
[Nicorandil in the treatment of patients with ischemic heart disease].
January 2013, Kardiologiia,
B A Sidorenko, and E N Botolova, and A A Golikova
[Problems in the treatment of patients with ischemic heart disease].
January 2000, Terapevticheskii arkhiv,
B A Sidorenko, and E N Botolova, and A A Golikova
[Plasmapheresis in the treatment of patients with ischemic heart disease].
December 1991, Vrachebnoe delo,
B A Sidorenko, and E N Botolova, and A A Golikova
[Amiodarone in the treatment of patients with ischemic heart disease].
May 1978, Vrachebnoe delo,
B A Sidorenko, and E N Botolova, and A A Golikova
[Euconol in the treatment of patients with ischemic heart disease].
January 1993, Kardiologiia,
B A Sidorenko, and E N Botolova, and A A Golikova
[Prophylactic treatment of patients with ischemic heart disease].
February 1974, Vrachebnoe delo,
Copied contents to your clipboard!